Escherichia coli invasion of brain endothelial cells
Project Number5R01AI040635-07
Contact PI/Project LeaderHUANG, SHENG-HE
Awardee OrganizationCHILDREN'S HOSPITAL OF LOS ANGELES
Description
Abstract Text
DESCRIPTION (provided by applicant): E. coli K1 is the most common gram-negative organism causing neonatal meningitis. One of the least understood issues in the pathogenesis of this disease is how circulating E. coli K1 crosses the blood-brain barrier (BBB) to cause brain injury. We have demonstrated in the in vitro and in vivo models of the BBB that E. coli K1 invasion is a complex process mediated by multiple E. coli invasion determinants, among which the 50-kDa protein encoded by ibeA is unique to E. coli K1. A bovine IbeA-binding protein (IbeABP) has been isolated by IbeA-affinity chromatography from brain microvascular endothelial cells (BMEC). The ibeA locus is a genetic island of meningitic E. coli (GimA) containing 15 genes, which consist of four operons, ptnlPKC, cglDTEC, gcxKRCI and ibeRAT. IbeA is an important virulence factor contributing to E. coli K1-mediated invasion in BMEC and the 14 other genes may involve in energy metabolism. The regulatory protein IbeR carrying an as4-interaction domain belongs to the NtrC/NifA family of transcriptional activators. It has been shown that anaerobic growth and glucose greatly enhanced E. coli K1 invasion of BMEC. Based on these results, we have hypothesized that the ibeA locus-mediated invasion and energy metabolism are coordinate events in pathogenesis of E. coli K1 meningitis. Interactions between IbeA and its receptor induce cellular responses that are required for E. coli entry of BMECs. Invasion gene expression is regulated by the genetic island GimA including IbeR and environmental signals. Our hypothesis will be tested through the following Specific Aims.
(1). To examine how IbeA contributes to E. coil K1 entry of human BMECs.
(2). To further characterize the role of IbeABP in E. coil K1 invasion of human BMEC.
(3). To determine how E. coil K1 invasion gene expression is regulated by the ibeA locus (GimA) including IbeR and environmental signals (glucose and oxygen tension).
National Institute of Allergy and Infectious Diseases
CFDA Code
856
DUNS Number
052277936
UEI
DVL1CMRMWRN9
Project Start Date
01-July-1997
Project End Date
31-December-2007
Budget Start Date
01-January-2004
Budget End Date
31-December-2004
Project Funding Information for 2004
Total Funding
$260,400
Direct Costs
$175,000
Indirect Costs
$85,400
Year
Funding IC
FY Total Cost by IC
2004
National Institute of Allergy and Infectious Diseases
$260,400
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AI040635-07
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AI040635-07
Patents
No Patents information available for 5R01AI040635-07
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AI040635-07
Clinical Studies
No Clinical Studies information available for 5R01AI040635-07
News and More
Related News Releases
No news release information available for 5R01AI040635-07
History
No Historical information available for 5R01AI040635-07
Similar Projects
No Similar Projects information available for 5R01AI040635-07